A Resolution recognizing the week of March 8 through 14, 2026, as "Multiple Sclerosis Awareness Week" in Pennsylvania.
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This resolution recognizes March 8-14, 2026, as ‘Multiple Sclerosis Awareness Week’ in Pennsylvania. It acknowledges the significant impact of multiple sclerosis, affecting approximately 24,000 Pennsylvanians, and highlights the National Multiple Sclerosis Society’s 79-year commitment to research and finding a cure for the disease. The resolution expresses appreciation for the Society’s efforts and encourages residents to support the fight against multiple sclerosis.
Key provisions
- Designates March 8-14, 2026, as ‘Multiple Sclerosis Awareness Week’ in Pennsylvania.
- Acknowledges the prevalence of multiple sclerosis in Pennsylvania.
- Recognizes the National Multiple Sclerosis Society’s 79-year history and contributions to research.
- Highlights the Society’s investment of over $1 billion in research.
- Expresses appreciation for the dedication of Pennsylvania chapters of the National Multiple Sclerosis Society.
Who is affected
- Individuals with Multiple Sclerosis
- Residents of Pennsylvania
- Families and caregivers of individuals with Multiple Sclerosis
Notable changes
- None – this is a resolution recognizing an existing awareness week.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Pn 2781 Html
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
9 on record
Primary sponsor
Robert Matzie
Cosponsors
Benjamin Sanchez
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours